Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02650804
Title BPM31510 Administered Intravenously With or Without Gemcitabine in Advanced Pancreatic Cancer Patients
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Berg, LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR


No variant requirements are available.